Profile | GDS4284 / 201777_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1054.3 | 75 |
GSM687648 | Patient 402 control | 612.197 | 67 |
GSM687653 | Patient 403 control | 944.654 | 74 |
GSM687658 | Patient 404 control | 662.559 | 68 |
GSM687663 | Patient 411 control | 976.61 | 73 |
GSM687668 | Patient 422 control | 872.618 | 72 |
GSM687673 | Patient 424 control | 1088.13 | 75 |
GSM687678 | Patient 425 control | 805.691 | 70 |
GSM687683 | Patient 427 control | 751.459 | 69 |
GSM687688 | Patient 428 control | 606.385 | 67 |
GSM687695 | Patient 441 control | 919.053 | 74 |
GSM687699 | Patient 443 control | 1149.58 | 76 |
GSM687704 | Patient 444 control | 904.051 | 72 |
GSM687707 | Patient 448 control | 1081.08 | 76 |
GSM687712 | Patient 449 control | 923.695 | 73 |
GSM687719 | Patient 450 control | 711.299 | 68 |
GSM687724 | Patient 451 control | 655.035 | 68 |
GSM687728 | Patient 452 control | 737.327 | 70 |
GSM687646 | Patient 401 treated 24h | 1029.19 | 74 |
GSM687649 | Patient 402 treated 24h | 671.929 | 68 |
GSM687665 | Patient 411 treated 24h | 999.574 | 74 |
GSM687651 | Patient 402 treated 4 weeks | 1107.44 | 75 |
GSM687667 | Patient 411 treated 4 weeks | 798.293 | 70 |
GSM687670 | Patient 422 treated 24h | 1146.26 | 76 |
GSM687671 | Patient 422 treated 4 weeks | 1124.1 | 75 |
GSM687654 | Patient 403 treated 24h | 775.424 | 71 |
GSM687675 | Patient 424 treated 24h | 1042.09 | 74 |
GSM687685 | Patient 427 treated 24h | 788.95 | 70 |
GSM687656 | Patient 403 treated 4 weeks | 1010.34 | 74 |
GSM687677 | Patient 424 treated 4 weeks | 664.064 | 67 |
GSM687687 | Patient 427 treated 4 weeks | 1015.36 | 74 |
GSM687692 | Patient 428 treated 4h | 666.895 | 68 |
GSM687716 | Patient 449 treated 4h | 997.906 | 74 |
GSM687722 | Patient 450 treated 4h | 625.112 | 66 |
GSM687680 | Patient 425 treated 24h | 896.188 | 72 |
GSM687690 | Patient 428 treated 24h | 846.77 | 72 |
GSM687700 | Patient 443 treated 24h | 1192.56 | 76 |
GSM687705 | Patient 444 treated 24h | 1031.33 | 75 |
GSM687714 | Patient 449 treated 24h | 874.452 | 72 |
GSM687721 | Patient 450 treated 24h | 910.776 | 73 |
GSM687682 | Patient 425 treated 4 weeks | 525.064 | 65 |
GSM687694 | Patient 428 treated 4 weeks | 382.735 | 60 |
GSM687702 | Patient 443 treated 4 weeks | 1118.21 | 75 |
GSM687718 | Patient 449 treated 4 weeks | 839.674 | 72 |
GSM687723 | Patient 450 treated 4 weeks | 769.718 | 70 |
GSM687661 | Patient 404 treated 4h | 553.963 | 65 |
GSM687710 | Patient 448 treated 4h | 917.364 | 73 |
GSM687726 | Patient 451 treated 4h | 764.671 | 70 |
GSM687730 | Patient 452 treated 4h | 423.676 | 51 |
GSM687660 | Patient 404 treated 24h | 634.865 | 68 |
GSM687697 | Patient 441 treated 24h | 901.708 | 73 |
GSM687709 | Patient 448 treated 24h | 1243.12 | 78 |
GSM687725 | Patient 451 treated 24h | 733.307 | 69 |
GSM687729 | Patient 452 treated 24h | 1115.54 | 78 |
GSM687727 | Patient 451 treated 4 weeks | 718.238 | 69 |
GSM687731 | Patient 452 treated 4 weeks | 941.087 | 73 |